AKYA - Akoya Biosciences, Inc.

QQQ $ 601.96 $ 12.51 (2.12 %)

DIA $ 461.18 $ 5.81 (1.28 %)

SPY $ 662.96 $ 10.02 (1.53 %)

TLT $ 90.50 $ -0.05 (-0.06 %)

GLD $ 377.97 $ 8.97 (2.43 %)

Previous Close

$ 1.29

Open

$ 1.39

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

-- - --

52 Week Range

$ 0.93 - $ 3.42

Volume

715,252

Average Volume

Market Cap

64.34M

Beta (5Y Monthly)

$ 1.82

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-12-2025	03-31-2025	10-Q
2	03-17-2025	12-31-2024	10-K
3	11-14-2024	09-30-2024	10-Q
4	08-05-2024	06-30-2024	10-Q
5	05-13-2024	03-31-2024	10-Q
6	03-04-2024	12-31-2023	10-K
7	11-08-2023	09-30-2023	10-Q
8	08-07-2023	06-30-2023	10-Q
9	05-09-2023	03-31-2023	10-Q
10	03-07-2023	12-31-2022	10-K
11	11-08-2022	09-30-2022	10-Q
12	08-08-2022	06-30-2022	10-Q
13	05-05-2022	03-31-2022	10-Q
14	03-14-2022	12-31-2021	10-K
15	11-09-2021	09-30-2021	10-Q
16	08-11-2021	06-30-2021	10-Q
17	05-19-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Tuesday's ...
06/03/2025 17:06:51

Kent Lake Raises Concerns Over Quanterix's...
05/23/2025 18:27:58

Kent Lake PR LLC ("Kent Lake"), a holder of approximately 6.9% of the outstanding common stock of Quanterix Corporation...

12 Health Care Stocks Moving In Wednesday'...
05/21/2025 17:06:44

12 Health Care Stocks Moving In Wednesday'...
05/21/2025 12:07:32

Akoya Announced Receipt Of Unsolicited Pro...
05/21/2025 10:06:22

https://www.sec.gov/ix?doc=/Archives/edgar/data/1711933/000155837025008039/akya-20250520x8k.htm

Canaccord Genuity Maintains Hold on Akoya ...
05/19/2025 15:13:55

Canaccord Genuity analyst Kyle Mikson maintains Akoya Biosciences (NASDAQ:AKYA) with a Hold and lowers the price target from...

Akoya Biosciences Q1 EPS $(0.32) Misses $(...
05/12/2025 20:43:01

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $...

Quanterix To Issue About 7.76M Shares, Pay...
04/29/2025 11:21:59

Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of CombinationQuanterix Corporation (NASDAQ:QTRX...

Akoya Biosciences And Enable Medicine Coll...
04/24/2025 12:02:12

Akoya Biosciences Expands Portfolio With A...
04/24/2025 12:01:28

Kent Lake, A 7.7% Shareholder Of Quanterix...
04/17/2025 12:38:38

Urges Shareholders to Vote AGAINST Both Proposals Related to the Value-Destructive Merger with Akoya at the Upcoming Special Me...

Piper Sandler Maintains Neutral on Akoya B...
04/14/2025 14:55:23

Piper Sandler analyst David Westenberg maintains Akoya Biosciences (NASDAQ:AKYA) with a Neutral and lowers the price target ...

Tikvah Management Calls On Quanterix To Ex...
04/14/2025 12:05:04

Tikvah Management LLC (together with its affiliates, "Tikvah" or "we"), which owns approximately 1.5% of the ou...

Akoya Biosciences And Team SAMBAI Select P...
04/02/2025 12:23:00

Akoya's technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer Equity Research, funded ...

this-brown--brown-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

This Brown & Brown Analyst Is No Longer Bu...
03/25/2025 14:57:05

Stephens & Co. Downgrades Akoya Bioscience...
03/25/2025 14:32:22

Stephens & Co. analyst Mason Carrico downgrades Akoya Biosciences (NASDAQ:AKYA) from Overweight to Equal-Weight and lowe...

Stephens & Co. Reiterates Overweight on Ak...
03/18/2025 13:40:10

Stephens & Co. analyst Mason Carrico reiterates Akoya Biosciences (NASDAQ:AKYA) with a Overweight and maintains $3.5 pri...

Kent Lake Urges Quanterix Management To Ad...
03/17/2025 20:09:09

Believes Proposed Transaction with Akoya Significantly Undervalues QuanterixEncourages Shareholders to Vote Against Transaction...

Akoya Biosciences Q4 2024 GAAP EPS $(0.17)...
03/17/2025 20:03:38

Akoya Biosciences (NASDAQ:AKYA) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $...

Kent Lake Issues Letter To Quanterix Share...
02/18/2025 20:42:52

Believes Merger Agreement Significantly Undervalues QuanterixKent Lake PR LLC ("Kent Lake"), a holder of 5.9% of the ou...